Denosumab with Immunotherapy for Liver Cancer Spread to Bones
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests whether adding denosumab (a bone-strengthening medication) to immunotherapy helps patients with liver cancer that has spread to their bones. Denosumab may help reduce bone pain and prevent fractures while the immunotherapy fights the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have hepatocellular carcinoma (liver cancer) confirmed by imaging or biopsy
- Cancer has spread to your bones, confirmed by imaging
- You are able to perform light activities (ECOG score 0–1)
- Your liver function is good enough for treatment (Child-Pugh A or stable B7)
- You have not received PD-1 inhibitors or similar immunotherapies before
- You are willing to have a dental assessment and avoid unnecessary dental work during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two drugs (sintilimab, an immunotherapy, and lenvatinib, a targeted therapy) followed by local treatments to try to cure advanced liver cancer that has spread to a few other parts of the body. The goal is to shrink the cancer enough that surgery or radiation can remove it completely.
This trial tests a combination of an immunotherapy drug (PD-1 inhibitor), a bone-strengthening drug (denosumab), and chemotherapy for people with advanced or spread non-squamous non-small cell lung cancer that does not have certain genetic changes. The goal is to see if this combination helps shrink tumors and control the disease.
This trial tests a new drug called SHR-2017 for people with solid tumors that have spread to the bones. The study aims to see if the drug can help manage pain and other effects of bone metastases.
This trial studies how tyrosine kinase inhibitor (TKI) medicines work against non-small cell lung cancer that has spread to the bone. It’s for people with specific “actionable” gene changes, to see how well these treatments reduce or change bone metastases.
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
This study tracks how a type of cancer treatment called anti-PD-1 immunotherapy affects bone strength over time. Researchers want to understand whether this treatment causes bone density loss and help develop ways to protect bones during cancer care.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.